Ibrutinib
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Ibrutinib |
| DrugBank ID | DB09053 |
| KG Predictions | 45 |
| DL Predictions (≥0.7) | 44 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 45 knowledge graph predictions and 44 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| mantle cell lymphoma | KG |
| B-cell neoplasm | KG |
| lymphoplasmacytic lymphoma | KG |
| lymphosarcoma | KG |
| Richter syndrome | KG |
| graft versus host disease | KG |
| macroglobulinemia | KG |
| Waldenstrom macroglobulinemia | KG |
| acute lymphoblastic/lymphocytic leukemia | KG |
| mantle cell lymphoma | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB09053
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.